PMDA drug package insert
メネシット配合錠100
PMDA Prescription drug · オルガノン株式会社 · package insert Feb 15, 2024
Key facts
| Brand names | メネシット配合錠100, メネシット配合錠250 |
|---|---|
| Nonproprietary names | レボドパ・カルビドパ水和物 |
| Companies | 製造販売元／オルガノン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | パーキンソニズム治療剤 |
| Therapeutic category codes | 871169 |
| YJ codes | 1169101F1146, 1169101F2053 |
| Approval numbers | 22100AMX00758000, 22100AMX00759000 |
| Package insert edition | 第3版 |
| Package insert date | Feb 15, 2024 |
| PMDA document key | 181615_1169101F1146_3 |
| PMDA company code | 181615 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: